Livers donated after cardiac death safe for patients with liver cancer
the ONA take:
According to a recent study published in the American Journal of Transplantation, researchers from Mayo Clinic in Jacksonville, Florida, have found that patients with liver cancer have the same positive outcomes using organs donated by patients who died as a result of cardiac death.
For the study, researchers identified 397 patients with liver cancer who received a new liver. Of those, 340 were from a person died after brain death and 57 were donated after cardiac death. Results showed that cancer recurrence occurred in about 12% of patients in both groups.
Previous studies have suggest that livers donated after cardiac death result in worse outcomes in patients with liver cancer because the liver has suffered oxygen deprivation.
"Our program has one of the largest experiences in the world with liver transplants using donations after cardiac death," says the study's lead investigator, transplant surgeon Kristopher P. Croome, M.D. "We now know that these organs effectively offer new life for patients with liver cancer."
Patients with liver cancer have the same positive outcomes using organs donated by patients who died as a result of cardiac death.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|